• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

The Glaucoma Foundation announces the winner of the 2023 Robert Ritch Award


Louis R. Pasquale, MD, FARVO, will be presented the award by previous winner Robert N. Weinreb, MD.

A man holding a gold trophy(Image Credit: AdobeStock/Shutter2U)

(Image Credit: AdobeStock/Shutter2U)

The Glaucoma Foundation’s (TGF) has announced Louis R. Pasquale, MD, FARVO as the winner of its 2023 Robert Ritch Award for Innovation and Excellence in Glaucoma.

In a press release from TGF, the organization states the award, named in honor of the founder of TGF, will be presented on June 9, during the 28th Annual Glaucoma Foundation Scientific Think Tank, to be held in New York City. The award will be presented to Pasquale by Robert N. Weinreb, MD, Chair of Ophthalmology at the University of California San Diego and the 2021 award recipient.

Pasquale is Site Chair of the Department of Ophthalmology at Mt. Sinai Hospital in New York, Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, and Vice Chair of Translational Ophthalmology Research for the Mount Sinai Healthcare System.

According to the press release, Pasquale has dedicated “considerable effort” to the discovery of preclinical factors that contribute to primary open-angle glaucoma (POAG), and primary prevention strategies in the open-angle glaucomas.

Pasquale is a member of the PLOS One, Journal of Glaucoma, Ophthalmology Glaucoma, Asia-Pacific Journal of Ophthalmology and American Journal of Ophthalmology editorial boards. He currently serves as Glaucoma Trustee for ARVO and is a member of the National Institute of Health’s National Advisory Eye Council.

Elena Sturman, TGF president and CEO, talked about the award in the press release.

“Dr. Pasquale’s career has impressively impacted multiple areas of glaucoma research. We congratulate him on his many achievements,” said Sturman.

Robert N. Weinreb discussed Pasquale and the award in the press release.

“I was pleased to learn that Lou Pasquale, MD has been selected this year as the recipient of the prestigious Robert Ritch Award,” said Weinreb. “Lou is among the most innovative individuals in our specialty. He has demonstrated repeatedly a combination of creativity and the ability to think outside the box. His many contributions have been diverse and each has advanced the medicine and science of glaucoma.”

Related Videos
© 2024 MJH Life Sciences

All rights reserved.